Business

SNT: Revenue and EBITDA soared on strong medical equipment and recurring sales, with robust outlook

SNT: Revenue and EBITDA soared on strong medical equipment and recurring sales, with robust outlook

Synektik SaJune 11, 20244
SNT: Revenue and EBITDA soared on strong medical equipment and recurring sales, with robust outlook

About this update from Synektik Sa

Revenue surged 71% year-over-year to 359 mln PLN, with normalized EBITDA up 93% and strong growth in medical equipment and recurring service sales. Robust cash flow, improved margins, and expansion in robotic surgery and radio-pharmaceuticals support a positive outlook.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Synektik Sa